- NHL Treatment
- Hodgkin's Treatment
- Clinical Trials
- Monoclonal Antibodies
- Types of NHL
Lymphoma and Pets
Free teleconferences: Newly Diagnosed and Advancing Therapies for Blood Cancers
NHL: A Guide to Treatment for the Newly Diagnosed
Date: June 15, 2010 - Tuesday
Beginning Time: 12:00 pm Eastern
End Time: 1:30 pm
Register for this free telephone/webcast education program. This program will feature John P. Leonard, MD, The Richard T. Silver Distinguished Professor of Hematology and Medical Oncology, Weill Cornell Medical College, New York, NY.
Participants will have the opportunity to ask the presenter questions during the program.
This program is sponsored by The Leukemia & Lymphoma Society and supported by grants from Genentech & Biogen Idec in collaboration with Abrale.
For more information contact:
Information Resource Center
Partners in Progress: An Expert Panel Discussion on Advancing Therapies for Blood Cancers
Free In-Person Education Program
Date: June 22, 2010 - Tuesday
Beginning Time: 5:30 pm Eastern
End Time: 7:30 pm
Register to participate by telephone or webcast.
Register to participate in person at Hackensack University Medical Center, Hekemian Conference Center, Hackensack, NJ.
This program will feature Gail J. Roboz, MD, Director, Leukemia Program, Associate Professor of Medicine and Maria Baldo, MS, PA-C, Senior Physician Assistant, Leukemia Service both from Weill Cornell Medical College of Cornell University in New York and Stuart L. Goldberg, MD, Chief, Division of Leukemia, John Theurer Cancer Center, Hackensack University Medical Center, Associate Clinical Professor of Medicine, University of Medicine & Dentistry of New Jersey and Louis J. DeGennaro, PhD, Executive Vice President and Chief Mission Officer, The Leukemia & Lymphoma Society, White Plains, New York and John J. Hughes, MDS Survivor and Clinical Trial Participant from Bayonne, New Jersey.
Participants will have the opportunity to ask the presenters a question during the program.
This program is sponsored by The Leukemia & Lymphoma Society and supported by an educational grant from Genentech and Biogen Idec and also supported by an educational donation from Amgen.